Despite a severe shortage of (and declining access to) primary care, insurers and employers remain skeptical of investing more in these doctors. Here’s why.
A recent OpenAI experiment revealed how fast GenAI is advancing, and why doctors and patients should rethink what’s technologically possible in medicine.
Two innovations offer a new path to healthcare affordability: GLP-1 medications and generative AI. Here’s how to two could radically improve medicine and lower costs.
The biggest healthcare savings from GenAI won’t come from cutting clinicians, but from preventing complications and improving patient health.
GenAI’s breakthrough in mathematics offers a lesson for medicine: solving healthcare’s biggest problems means questioning old assumptions.
Generative AI could save lives by improving chronic disease care, after-hours guidance and clinical decision-making — if medicine moves faster.
A physician and Informatics expert makes the case for why doctors are needed more than ever even when AI tools outperform them.
Paris-based Mistral wanted to develop a top-tier AI model to rival OpenAI and Anthropic. That didn’t work out. But it turns out lots of folks don’t care if the AI is bleeding edge – as long as it wasn’t made in America or China.
Forbes’ AI 50 list spotlights the most promising privately held companies applying artificial intelligence to solve real-world challenges.
56% of CEOs report no AI ROI. New reports from PwC, Anthropic, and OpenAI reveal why usage doesn’t equal value—and what metrics boards should track instead.